Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02399969 · ClinicalTrials.gov registry record · Phase 1

Battlefield Acupuncture for the Treatment of Low Back Pain in the Emergency Department

A Phase 1 study of Low Back Pain, sponsored by Icahn School of Medicine at Mount Sinai.

Completed
Registry status
Phase 1
Development phase
30
Enrollment target
1
Study location

NCT02399969: Completed Phase 1 study of Low Back Pain, sponsored by Icahn School of Medicine at Mount Sinai.

NCT02399969 is a Phase 1 study of Low Back Pain that has completed, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 30 participants, below the 504-participant average among 122 other Low Back Pain trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02399969, a Phase 1 study of Low Back Pain, has completed, sponsored by Icahn School of Medicine at Mount Sinai.

COMPLETED
Registry status
Phase 1
Development phase
30 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to study acupuncture for the treatment of low back pain in the emergency department. Current treatments for low back pain in the emergency department generally include pills or injections of medications to treat pain and relax muscles. However, it is known that many of these medications have risks and toxicities which may limit their safe use in some patients. Therefore, new types of treatments are needed. Acupuncture is an ancient form of healing that has been practiced in some form for centuries. In modern times, acupuncture has been studied for the long-term treatment of low back pain and some research suggests it may be effective. However, very little research has examined the use of acupuncture for immediate pain relief in the emergency department. This research will study a type of acupuncture called Battlefield Acupuncture (BFA). Battlefield acupuncture was designed by a physician in the US military with the purpose of providing immediate pain relief. It involves the placement of 5 small needles in each ear. The needles may be removed at any time. The hypothesis of this study is that battlefield acupuncture may improve mobility and pain of patients with low back pain in the emergency department.

Primary Outcome

Time that a person takes to rise from a chair, walk three meters, turn around, walk back to the chair, and sit down, will be monitored in seconds. If a person cannot get up in 30 seconds to ambulate, they will be cut off.

Conditions Studied

Interventions

  • OTHER Battlefield Acupuncture

Study Locations (1)

New York

  • Icahn School of Medicine at Mount Sinai - New York

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2015-03
Est. Completion 2016-04
Phase Phase 1

What the finished NCT02399969 record still lists

NCT02399969 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 504-participant average among 122 other Low Back Pain trials with a reported enrollment target (94% lower).

The record links to 1 condition, with Low Back Pain appearing as the primary indexed condition, and to 1 intervention - of which Battlefield Acupuncture is the first listed.

NCT02399969 reports a single indexed study location in New York.

Frequently Asked Questions

What is clinical trial NCT02399969 about?

NCT02399969 is a clinical study titled "Battlefield Acupuncture for the Treatment of Low Back Pain in the Emergency Department". The purpose of this study is to study acupuncture for the treatment of low back pain in the emergency department. Current treatments for low back pain in the emergency department generally include pills or injections of medications to treat pain and relax muscles. However, it is known that many of t...

What is the current status of trial NCT02399969?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 30 participants. The study started on 2015-03. Estimated completion is 2016-04.

What conditions does trial NCT02399969 study?

This clinical trial studies the following conditions: Low Back Pain.

What interventions are being tested in trial NCT02399969?

The interventions under investigation include: Battlefield Acupuncture (OTHER).

Who is sponsoring clinical trial NCT02399969?

This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02399969 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Low Back Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02399969's enrollment target sits among peer trials

30 106th of 122 higher than 13 of 122 other Low Back Pain trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Low Back Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00977977 · 30 participants · Phase 2

    Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy

  • NCT01459107 · 30 participants · Phase 2

    Human Upper Extremity Allotransplantation

  • NCT01666080 · 30 participants · NA

    Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)

  • NCT01720836 · 30 participants · Phase 1

    Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02399969, the US trial registry maintained by the National Library of Medicine. NCT02399969 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.